![Logo for ABIVAX Société Anonyme](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2Faf138-2024-07-16-11-13-18.png&w=256&q=100)
ABIVAX Investor Relations Material
Latest events
![Logo for ABIVAX Société Anonyme](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2Faf138-2024-07-16-11-13-18.png&w=128&q=100)
H2 2023
ABIVAX
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from ABIVAX Société Anonyme
Access all reports
ABIVAX Société Anonyme is a clinical-stage biotechnology company that focuses on developing therapeutics designed to modulate the body's natural immune regulatory mechanisms. The company is primarily engaged in advancing its lead drug candidate, obefazimod, which is currently undergoing clinical trials aimed at treating moderately to severely active ulcerative colitis. Additionally, ABIVAX is exploring obefazimod's potential in treating other chronic inflammatory diseases, including Crohn's disease, through ongoing clinical trials and research initiatives. The company is headquartered in Paris, France, and its shares are listed on both the Nasdaq and the Euronext Paris.
Key slides for ABIVAX Société Anonyme
![Obefazimod returned](/_next/image?url=https%3A%2F%2Fcdn.quartr.com%2Fimages%2Fconference-calls%2Fabivax-socit-anonyme-corporate-presentation-be1b6fc649f24701%2F44.png&w=3840&q=75)
![Logo for ABIVAX Société Anonyme](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2Faf138-2024-07-16-11-13-18.png&w=128&q=100)
Corporate Presentation
ABIVAX Société Anonyme
![ABTECT Study : Enrol](/_next/image?url=https%3A%2F%2Fcdn.quartr.com%2Fimages%2Fconference-calls%2Fabivax-socit-anonyme-corporate-presentation-be1b6fc649f24701%2F37.png&w=3840&q=75)
![Logo for ABIVAX Société Anonyme](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2Faf138-2024-07-16-11-13-18.png&w=128&q=100)
Corporate Presentation
ABIVAX Société Anonyme
Latest articles
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F2000x1125%2Fbbbaafadba%2Fpontis-dackmo_strong-opinions-loosely-held.png&w=3840&q=75)
Strong Opinions, Loosely Held: Pontus Dackmo on Flexibility and Market Psychology
After a two-decade career in finance, Pontus Dackmo co-founded Protean Funds Scandinavia in 2022, where he now serves as CEO and Investment Manager.
4 Sep 2024
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F2000x1125%2F7455f6afd1%2Fnovo-nordisk_the-danish-pharmaceutical-titan.png&w=3840&q=75)
Novo Nordisk: The Danish Pharmaceutical Titan Revolutionizing Global Healthcare
Novo Nordisk's rise to becoming Europe's largest company, reshaping global healthcare and Denmark's economy.
5 Sep 2024
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F2000x1125%2F5533bee49f%2Fthe-toyota-way.png&w=3840&q=75)
The Toyota Way: Revolutionizing Global Manufacturing
Explore how Toyota's Lean Manufacturing and Kaizen principles revolutionized production and quality, setting global benchmarks for excellence.
2 Sep 2024
Ticker symbol
ABVX
Country
🇫🇷 France